BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28073801)

  • 1. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M;
    Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does disease activity at start of biologic therapy influence work-loss in RA patients?
    Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
    Rheumatology (Oxford); 2016 Apr; 55(4):729-34. PubMed ID: 26683196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
    Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LT; Petersson IF
    Ann Rheum Dis; 2013 Oct; 72(10):1675-9. PubMed ID: 23148309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
    Neovius M; Simard JF; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Aug; 70(8):1407-14. PubMed ID: 21518724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson JÅ; Geborek P; Jacobsson LT; Askling J; Neovius M
    Ann Rheum Dis; 2014 May; 73(5):845-53. PubMed ID: 23520035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
    Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S
    JAMA Intern Med; 2013 Aug; 173(15):1407-14. PubMed ID: 23817631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
    Kristensen LE; Petersson IF; Geborek P; Jöud A; Saxne T; Jacobsson LT; Englund M
    Rheumatology (Oxford); 2012 Feb; 51(2):243-9. PubMed ID: 21565900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
    Olofsson T; Englund M; Saxne T; Jöud A; Jacobsson LT; Geborek P; Allaire S; Petersson IF
    Ann Rheum Dis; 2010 Dec; 69(12):2131-6. PubMed ID: 20693274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work.
    Hansen SM; Hetland ML; Pedersen J; Østergaard M; Rubak TS; Bjorner JB
    Rheumatology (Oxford); 2017 Jul; 56(7):1135-1143. PubMed ID: 28371921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.
    Wallman JK; Jöud A; Olofsson T; Jacobsson LTH; Bliddal H; Kristensen LE
    Rheumatology (Oxford); 2017 May; 56(5):716-724. PubMed ID: 28064208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
    Manders SH; Kievit W; Braakman-Jansen AL; Brus HL; Hendriks L; Fransen J; van de Laar MA; van Riel PL
    J Rheumatol; 2014 Jul; 41(7):1263-9. PubMed ID: 24833758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
    Raaschou P; Simard JF; Neovius M; Askling J;
    Arthritis Rheum; 2011 Jul; 63(7):1812-22. PubMed ID: 21305513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
    Verstappen SM; Watson KD; Lunt M; McGrother K; Symmons DP; Hyrich KL;
    Rheumatology (Oxford); 2010 Aug; 49(8):1570-7. PubMed ID: 20444856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
    Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
    Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.
    Allaire S; Wolfe F; Niu J; Zhang Y; Zhang B; LaValley M
    Arthritis Rheum; 2008 Aug; 59(8):1082-9. PubMed ID: 18668597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with ulcerative colitis miss more days of work than the general population, even following colectomy.
    Neovius M; Arkema EV; Blomqvist P; Ekbom A; Smedby KE
    Gastroenterology; 2013 Mar; 144(3):536-43. PubMed ID: 23232295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Self-Assessed Future Work Ability and Long-Term Sickness Absence, Disability Pension and Unemployment in a General Working Population: A 7-Year Follow-Up Study.
    Lundin A; Kjellberg K; Leijon O; Punnett L; Hemmingsson T
    J Occup Rehabil; 2016 Jun; 26(2):195-203. PubMed ID: 26319413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.